Biologics

AlloSource’s New Cartilage Repair Product, ProChondrix, Receives Patent

CENTENNIAL, Colo.Jan. 19, 2016 /PRNewswire-USNewswire/ — AlloSource®, one of the nation’s largest providers of cartilage, cellular, bone, skin and soft-tissue allografts for use in surgical procedures and wound care to advance patient healing, was awarded U.S. Patent Number 9,186,253, titled Cartilage mosaic compositions and methods, for its new cartilage repair allograft, ProChondrix® Cartilage Restoration Matrix.

ProChondrix is a cellular 3D fresh cartilage matrix that helps deliver the necessary components for cartilage restoration. This next generation of cartilage therapy provides live functional cells and other biological components necessary for repair and regeneration of damaged cartilage tissues.

“With thousands of cartilage repair surgeries performed in the U.S. each year, this is another opportunity for donor tissue to improve lives,” said Dr. Peter Stevens, PhD, AlloSource Vice President of Development and Growth. “The initial feedback from surgeons on ProChondrix has been positive and we look forward to continued collaboration in helping patients heal.”

By focusing on quality, safety, service and a commitment to its mission, AlloSource has grown into one of the nation’s largest tissue networks. The company’s safety and tissue processing standards meet and exceed guidelines set forth by the United States Food and Drug Administration (FDA) and the American Association of Tissue Banks (AATB).

About AlloSource
AlloSource is one of the largest nonprofit cellular and tissue networks in the country, offering more than 200 types of precise cartilage, cellular, bone, skin and soft-tissue allografts to advance patient healing. For more than 20 years, AlloSource’s products have bridged the proven science of allografts with the advanced technology of cells, offering life-saving and life-enhancing possibilities in spine, sports medicine, foot and ankle, orthopedic, reconstructive, trauma and wound care procedures. As the world’s largest processor of cellular bone allografts, fresh cartilage tissue for joint repair and skin allografts to help heal severe burns, AlloSource delivers unparalleled expertise and service to its growing network of surgeons, partners, and the country’s most reputable organ procurement organizations. The company is accredited by the American Association of Tissue Banks and is headquartered in Centennial, CO. For more information, please visit allosource.org or our educational website, allograftpossibilities.org.

Media Contact
Megan Duggan
AlloSource
720. 382. 2766
mduggan@allosource.org

 

SOURCE AlloSource

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button